Abiopharma

New Form 8-K - Immunovant, Inc. Filed: 2025-09-03 AccNo: 0001764013-25-000136 Size: 3 MB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits